Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Long-Term Deferred Tax: 2011-2023

Historic Long-Term Deferred Tax for National Research (NRC) over the last 6 years, with Q3 2023 value amounting to $4000.0.

  • National Research's Long-Term Deferred Tax fell 7647.06% to $4000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $4000.0, marking a year-over-year decrease of 7647.06%. This contributed to the annual value of $14000.0 for FY2022, which is 0.0% changed from last year.
  • National Research's Long-Term Deferred Tax amounted to $4000.0 in Q3 2023, which was down 7647.06% from $8000.0 recorded in Q2 2023.
  • In the past 5 years, National Research's Long-Term Deferred Tax registered a high of $18000.0 during Q2 2022, and its lowest value of $4000.0 during Q3 2023.
  • Moreover, its 3-year median value for Long-Term Deferred Tax was $14000.0 (2021), whereas its average is $12875.0.
  • In the last 5 years, National Research's Long-Term Deferred Tax changed by 0.0% in 2022 and then crashed by 7647.06% in 2023.
  • National Research's Long-Term Deferred Tax (Quarter) stood at $14000.0 in 2021, then changed by 0.0% to $14000.0 in 2022, then plummeted by 71.43% to $4000.0 in 2023.
  • Its Long-Term Deferred Tax was $4000.0 in Q3 2023, compared to $8000.0 in Q2 2023 and $11000.0 in Q1 2023.